Columns

In the U.K., stand-up comedy is currently dead. Like Python’s parrot, it “wouldn’t move if you put 4,000 volts through it!” That’s not strictly true. Our government has just stumped up 1.57 billion pounds ($1.97 billion) to support the arts that were slammed shut by the crisis. Comedy is…

I’d just gotten out of bed the other morning and was headed to the bathroom using just one cane when I tried to step over a dog toy on the floor. I went down slowly onto the carpet, so it was really no big deal. No harm, no foul, but…

I have long preached the merits of acceptance. In embracing my MS, I have mitigated much of the accompanying fear. This modus operandi has enabled me to live alongside my disease as opposed to clashing with it. While ideal, it is becoming increasingly difficult to follow my advice. Two…

I saw this question asked in a group somewhere not long ago and it got me thinking. Would I go back to the way I was before my multiple sclerosis diagnosis? No, I wouldn’t.  That may sound strange, I…

B-Cells Infected by Epstein-Barr Virus Linked to MS Relapse Risk in Study I usually steer clear of mouse studies. Mice lie and monkeys exaggerate, some researchers say. But this is another piece to add to the growing pile of evidence that there’s a great big link between multiple sclerosis…

In this case, the woman in question was yet again my wife, Jane. The hour in question was 4 p.m. on my usual day of writing. But on this day, writing had to be forgotten until a stint later at night (yawn). I had an entertainment Zoom call to partake…

July is Disability Pride Month. Now, don’t slam me right away for writing this, but I don’t think we need a month highlighting disability pride — just like I don’t think we need a month in October spotlighting that we have rare diseases, especially because to me, multiple sclerosis…

Yup, it’s the annual whinge about what heat does to most of us, this time livened up by a headline that includes two Beatles’ song titles. (Yes, I did have to scroll through their discography to find the deeply submerged second — a George Harrison number off “Yellow…

PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients As more and more neurologists turn to telemedicine for routine patient visits, I expect we’ll see more of the type of technology being developed here. This group is working on something that goes further than what…

Our thoughts influence our being. The stories we tell ourselves frame our reality. They affect the decisions we make, our behaviors, and ultimately our overall mindset. These serve to either nourish or starve our psyche. If we are what we eat, then are we what we think? Absolutely. We cannot…

Note: This column was updated July 23, 2020, to remove erroneous information about red blood cells. We regret the error.  When I was newly diagnosed seven years ago, one of the hardest things to deal with was the idea of having…

NICE Does Not Favor Adding Mayzent to NHS England for Active SPMS Currently, the only disease-modifying therapy approved for use in the National Health Service is Betaferon (interferon beta-1b). That’s a 20-year-old treatment considered to be one of the least effective of the DMTs. NICE concedes that clinical trials…

Last Wednesday my days of rest suddenly smashed to a halt. At one point it seemed like the majority of those who work for my local council’s social services (whom I should have also thanked for their immense help over the last few weeks, mea culpa) were squeezed into…

It’s been a few weeks since I’ve written about the impact that COVID-19 is having on people with MS. Since then, the picture has changed — not a lot, but enough for the MS International Federation to modify its recommendations for that illness, people with MS, and…

Over the years, I have observed how others deal with multiple sclerosis and its symptoms. This disorder is not one-size-fits-all, and it doesn’t discriminate. Recently, I came across a video of ABC News interviewing actress Selma Blair about her multiple sclerosis diagnosis and management. Although the interview happened over…

I’m a fraud. Or at least I feel like one.  When writing for a site about multiple sclerosis and setting up a business focused on my diagnosis to help others in the same boat, it is a requirement that I…

Gilenya May Help Control Severe Respiratory Disease in COVID-19 This story caught my eye, but not because of the possibility that Gilenya may help someone recover from COVID-19. It caught my eye because this information may give false hope to some people. Some doctors think that at a…

My family just returned from a lovely week-long vacation on the Gulf of Mexico. It’s always a wonderful time (and one perfectly suited to socially isolating) because we literally do nothing. We make no plans. We buy no tickets to any event or theme park. We sleep, read, and watch…

It hasn’t been that quiet in my surrounding world! Last week there was a crow fight so loud in our back garden that it echoed down the chimney into the front room that now is my bedroom. It sounded exactly like being in Hitchcock’s horror film “The Birds.”…

A couple new mobile apps for people with MS have caught my attention. Icompanion is among the best symptom and treatment trackers I’ve found. BelongMS combines patient forums with the ability to ask questions of healthcare specialists. Icompanion Several mobile apps allow users to enter information about how…

Editor’s note: “Need to Know” is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? Visit our forum. This week’s question is inspired by the forum post, “Do you have eye issues due to MS?,” published Oct. 28, 2018.

I like my husband. I like his generous heart, his humility, and his penchant for Tommy Bahama shorts, T-shirts, and flip-flops. Sure, I love him. Yet our love has changed throughout our 23-year marriage. We have traded passion for patience and lust for loyalty. While each exists, they are…

Last updated April 25, 2023 In June, the U.K. marks Carers Week, which got me thinking about how a chronic illness diagnosis often affects a patient’s entire family.  Most often, patients are the focus of a diagnosis, and the people around them are almost forgotten. The…

Note: A story mentioned in this column, “Prime Signs Agreement With EMD Serono to Improve Mavenclad’s Cost-benefit Value,” was updated on June 15, 2020, to clarify that the agreement allows for possible reimbursement for Prime’s health plan clients, not patients…

Ah, it’s not the blank page that all writers fear that I’m worried about. Those days have long left me. Now it’s applying the discipline to stop! When I first started with a professional writing commission, I sat in the office all day with that fear freezing me. (Those were…

Are you tired? Really tired? Me, too. Most of us with multiple sclerosis are. How many is most? A small new study of 44 people with one of the progressive forms of MS found that the answer is a little over 86%. (I’m surprised the number isn’t higher.) They…

Editor’s note: “Need to Know” is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? Visit our forum. This week’s question is inspired by the forum post “I’ve Been Spoiled by My Clinical Trial,” published March 5. Share your…

If laughter is the best medicine, then I have a functional pharmacy. I love to laugh and enjoy humor. If you are a friend of mine, then you know my dry wit. I use that wit to shield anxiety and fear. I ease the tension by creating humor. I…

Who wants to go on holiday?!  I know, I know, we can’t physically go anywhere right now, but what if I told you that you could go anywhere you wanted while staying at home? Stay with me! It’s been really sunny and blindingly hot in the U.K.

FDA Extends Review of Ofatumumab for Relapsing MS to September The U.S. Food and Drug Administration (FDA) was expected to make a decision about ofatumumab, a self-administered injection of a monoclonal antibody, by this month. Now, it looks as if we’ll be waiting until fall. Ofatumumab is already approved…